← Back to News

Align Technology (ALGN): Record Aligner Shipments and Stifel Stays Bullish at $210

positiveAnalyst ratingMulti dayYahoo Finance ·27 May 2026Original article ↗
Oraklio AI Analysis
Confidence 72%

While the news is clearly about Align Technology (ticker ALGN), ALGN is not present in the provided active_symbols list, so the dashboard cannot map it to a tradable symbol.

Article

Align Technology (ALGN): Record Aligner Shipments and Stifel Stays Bullish at $210 Abdul Rahman Wed, May 27, 2026 at 11:56 PM GMT+2 2 min read ALGN SF Align Technology, Inc. (NASDAQ: ALGN ) is one of the best medical technology stocks to buy right now . On May 18, Stifel analyst Jonathan Block reaffirmed his Buy rating and $210 price target on Align Technology, Inc.

(NASDAQ:ALGN) following a routine update to the firm’s financial model. Align Technology (ALGN): Record Aligner Shipments and Stifel Stays Bullish at $210 Align Technology (ALGN): Record Aligner Shipments and Stifel Stays Bullish at $210 The model update incorporated clear aligner volume data that Align Technology has recently started disclosing regularly alongside its earnings reports and presentations. Stifel also reviewed Align’s latest 10-Q filing and used it to inform observations on valuation, the analyst said.

Block stated that Align’s Q1 2026 earnings influenced the updated model heavily. In the earnings report shared on April 29, revenue came in at $1. 04 billion, up 6.

2% year over year. Management credited the revenue growth to record clear aligner shipments and higher average selling prices. Clear aligner revenue specifically surged 7.

4% year over year to $856 million, driven by volume growth, price increases, favorable foreign exchange, and lower net revenue deferrals. GAAP EPS for the quarter was $1. 57 per diluted share, up from $1.

26 in Q1 2025. This EPS jump came on the back of higher gross margins, lower tax rate, and buybacks reducing the share count, management noted. Stifel’s $210 target has been in place since February, when the firm raised it from $200 after concluding that Align could deliver mid-single-digit comparable growth for the year.

The firm calculated that this growth would support a share price in the $205-$215 range. Align Technology, Inc. (NASDAQ:ALGN) is a medical technology company specializing in digital orthodontics and restorative dentistry solutions.

The company is best known for its Invisalign clear aligner system, along with its iTero intraoral scanners and exocad dental CAD/CAM software platforms used by orthodontists and dentists worldwide. While we acknowledge the potential of ALGN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the   best short-term AI stock .

READ NEXT:  7 Best Augmented Reality Penny Stocks to Buy and 10 Best Gene Therapy Stocks to Buy in 2026 . Disclosure: None. Follow Insider Monkey on Google News .

Oraklio AI Trading Intelligence

News is just the start.

Oraklio turns news, price data, and market signals into structured BUY / SELL / NO_TRADE calls — updated continuously throughout the trading day.

Get started free

Already have an account? Sign in →